Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.44 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.44 |
| ▸ | NQO1 | P15559 | 2/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 5/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.39 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4510109 | 1.00 | CYSLTR2 (0.44) | CYSLTR2CYSLTR1NQO1ABCG2L3MBTL1 | |
| SCHEMBL4520592 | 0.91 | NQO1 (0.42) | CYSLTR2CYSLTR1NQO1ABCG2L3MBTL1 | |
| SCHEMBL4520585 | 0.91 | NQO1 (0.42) | CYSLTR2CYSLTR1NQO1ABCG2L3MBTL1 | |
| SCHEMBL13818099 | 0.90 | PADI4 (0.38) | NQO1L3MBTL1CYP1A1CYP1A2CYP2D6 | |
| SCHEMBL4520688 | 0.88 | NQO1 (0.42) | NQO1ABCG2L3MBTL1CYP1A1CYP1A2 | |
| SCHEMBL4520684 | 0.88 | NQO1 (0.42) | NQO1ABCG2L3MBTL1CYP1A1CYP1A2 | |
| SCHEMBL2280086 | 0.86 | PADI4 (0.48) | CYSLTR2CYSLTR1NQO1ABCG2L3MBTL1 | |
| SCHEMBL2280088 | 0.86 | PADI4 (0.48) | CYSLTR2CYSLTR1NQO1ABCG2L3MBTL1 | |
| SCHEMBL4527547 | 0.86 | BCHE (0.44) | NQO1ABCG2ALDH1A1LMNA | |
| SCHEMBL4527553 | 0.86 | BCHE (0.44) | NQO1ABCG2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090143368-A1 | Use of Cinnamoyl Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-06-04 | — | — | US | disclosed |
| EP-1857104-A1 | USE OF CINNAMOYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2007-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143368-A1 | Use of Cinnamoyl Compound | COL2A1, COL1A1, SMAD2 | CYSLTR2 1079/4885CYSLTR1 1024/4885NQO1 1490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.